Endoceutics
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2795 Laurier Blvd Ste 500, Quebec, Quebe...Phone Number
(418) 653-0033Website
www.endoceutics.comRevenue
$8.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Endoceutics
Endoceutics, Inc. is a Quebec-based company focused on women's health, particularly in the prevention and treatment of hormone-sensitive cancers. The company's main objective is to provide women worldwide with effective and physiological treatments for menopause-related issues, including vaginal atrophy, hot flashes, bone loss, and muscle loss, without negative side effects. Endoceutics is known for its product Intrarosa, which offers a new treatment option for postmenopausal women suffering from vulvovaginal atrophy. The company is actively engaged in investor solicitation and has announced new developments related to its offerings.Explore more
Endoceutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Endoceutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Endoceutics has new funding data
Endoceutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Endoceutics recently announced quarterly report
Product Launch: Get notified when Endoceutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Endoceutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Endoceutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Endoceutics is spiking on competitors!
Check if Endoceutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Endoceutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Endoceutics
Compare insights from companies similar to Endoceutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Endoceutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Endoceutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endoceutics.
Endoceutics financials insights
Gather financial insights about Endoceutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Unspecified
$85M
Endoceutics Tech Stack
A closer look at the technologies used by Endoceutics
Most Recent Scoops
Divestiture
Divestitures, Intellectual Property
Lateral Move
Executive Move
Jaâfar Zerhouni has transitioned from Vice President, QA & Product Development to the role of Vice President, Manufacturing & Product Development.
Executive Moves, Lateral Move, Quality Assurance, Product Development
Funding
Endoceutics recently secured $85 million in debt financing. CRG L.P. led the investment.
Funding
Funding
Endoceutics News & Media
Theramex Australia Enters Partnership With Endoceutics For Intrarosa® For The Treatment Of Postmenopausal Vulvovaginal Atrophy
SYDNEY--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has expanded its original agreement with Endoceutics to commercialise Intrarosa® (prasterone) in Australia. Intrarosa is now available in this market as the first and only locally acting DHEA (dehydroepiandrosterone) treatment indicated for postmenopausal women experiencing moderate to severe symptoms associated with vulvovaginal atrophy (VVA).1 Intrarosa is formulated as a 6.5 mgAMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone
Study Suggests that While All Postmenopausal Women Benefit from Treatment with Prasterone (INTRAROSA ® ), Women Experience Greatest Relief of Moderate to Severe Dyspareunia when started on INTRAROSA ® within One to Two Years after MenopauseTheramex to Exclusively License Intrarosa® In Europe, Australia, Russia and The Ukraine from Endoceutics
LONDON and QUEBEC CITY, July 19, 2018 /PRNewswire/ -- STRICTLY FOR EUROPEAN BUSINESS AND MEDICAL TRADE MEDIA ONLY Intrarosa® is an innovative treatment for vulvovaginal atrophy in post-menopausal women Strengthens Theramex's position as a leader in Women's Health ...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Endoceutics
Sign Up For FreeTo access detailed company insights
Endoceutics, Inc. is a Quebec-based company focused on women's health, particularly in the prevention and treatment of hormone-sensitive cancers. The company's main objective is to provide women worldwide with effective and physiological treatments for menopause-related issues, including vaginal atrophy, hot flashes, bone loss, and muscle loss, wit... Read More
